Hepcludex 2 mg, Pulver zur Herstellung einer Injektionslösung
7680683380014
CH-68338
Pulver
Associated product:
HEPCLUDEX subst sèche 2 mg flac 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.63 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5898.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2025
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 68338
- Drug name
- Hepcludex, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULVL
- ATC Code
- J05AX28
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 05/02/2024
- Authorization expiration date
- 04/02/2029
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- HEPCLUDEX subst sèche 2 mg flac 30 pce
- Description (DE)
- HEPCLUDEX Trockensub 2 mg Durchstf 30 Stk
- Market launch
- 05/02/2024
- Narcotic (BTM)
- No